Current News

Print version | PDF version | Send article | RSS-Feed

Fluidigm Singapore launches Biomedical Product Development Centre
Singapore R&D center to develop life science instruments targeted for US$650 million market

05 Feb 2007 - Fluidigm accelerates its R&D and manufacturing activities in Singapore, through the launch of its new Biomedical Product Development Center. This center, a core part of Fluidigm's worldwide R&D organization, will be responsible for the full development of a Fluidigm BioMark II series of instrumentation.
 
The center's initial research activities will support the development of instrumentation for the BioMark II system. The Singapore research group will undertake 100% of the R&D on a new biochip fluorescence reader and biochip loader, specially designed for high-throughput genotyping and protein expression applications. Fluidigm Singapore will also manufacture the BioMark II system.
 
Operations for the Biomedical Product Development Center will commence immediately, with its current R&D team of 5. Additional staff will be recruited from Singapore's pool of manufacturing and research expertise. The R&D center will also be supported by the local precision engineering companies, academic, biomedical and pharmaceuticals research institutions.